Should AI development be paused or restricted?
This is a genuinely contested question among experts, policymakers, and the public, with reasonable people landing in different places. Rather than search for a definitive "answer" (there isn't one — this is a values-and-risk-tradeoff debate, not a factual question), let me lay out the actual landscape of arguments, since that's more useful than me asserting a verdict.
The case for pausing or restricting AI development
The case against pausing (or for lighter-touch regulation)
A middle ground many propose
Many AI governance experts (and increasingly, policymakers) favor neither an outright pause nor a free-for-all, but targeted measures: mandatory safety testing/evaluations before deploying frontier models, transparency and incident-reporting requirements, liability rules, export controls on advanced chips, and international coordination bodies (akin to nuclear or biosafety regimes). This is roughly the direction of the EU AI Act, the US executive actions under Biden (since partly rolled back), and ongoing UK/international AI safety summits.
My honest take
I don't think there's a single correct answer independent of your values and risk tolerance. If you weight catastrophic/irreversible risks heavily and are skeptical of self-regulation, restriction looks more attractive. If you weight near-term benefits, competitive/geopolitical dynamics, and skepticism about regulatory capture, lighter-touch oversight with targeted safeguards looks better. Most serious proposals today aren't "pause everything" vs. "no rules" — they're about which specific restrictions (testing, transparency, liability, compute governance) at which capability thresholds.
If you want, I can dig into a specific angle — e.g., what the 2023 pause letter actually proposed, current EU/US regulatory status, what AI safety researchers at specific labs argue, or the state of international coordination efforts (like AI safety summits) in 2025-2026.